High prevalence of target diseases in rural and developing nations, increased prevalence of malnutrition across the globe, lack of hygiene and poor sanitation facilities, Migratory patterns of population, introduction of new chemical entity in the field of therapeutics, favorable government regulations, and increased RD investments are key factors contributing to high CAGR of point of care diagnostics market during the forecast period.
The global Leishmaniasis Treatment market was valued at USD 104.8 million in 2018 and is expected to reach USD 206.5 million by the year 2026, at a CAGR of 8.8%. A disease outbreak takes place when a disease escalates by a higher number than expected in a region or during a season. An outbreak may occur in one community or even extend to several countries altogether. There was a time when people in all countries and on all continents remain chronically vulnerable to infectious diseases, known and unknown. Leishmaniasis was the neglected tropical disease (NTD) that has threatened the people worldwide as per the WHO. Leishmaniasis is a major complex of protozoal vector-borne diseases that affects both humans and animals. The disease is caused by different species of Leishmania, and it is manifested by three major clinical forms named as cutaneous, mucosal and visceral leishmaniasis. Leishmaniasis is transmitted by the bite of infected female sand flies. In each of these forms, infection ranges from causing no symptoms (asymptomatic infection) to severe, even life-threatening complications.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2153
Key Companies in the market include:
Sanofi S.A., Sequus Pharmaceuticals Inc., Paladin Labs Inc., Enzon Pharmaceuticals Inc., Profounda, Inc., Gland Pharma Limited, Gilead Life sciences, and Lifecare Innovations Private Limited.
Regional segmentation comprises of a current and forecast estimation of the market in the key geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East Africa. The report also covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region, and robust presence of key players in the region.
Market segment analysis:
Disease Type (Revenue, USD Million; 2016–2026)
- Cutaneous Leishmaniasis
- Diffuse Cutaneous Leishmaniasis
- Mucocutaneous Leishmaniais
- Mucosal Leishmaniasis
- Visceral Leishmaniasis
Pathological tests (Revenue, USD Million; 2016–2026)
- By Serological Tests
- Direct Agglutination Test
- Indirect Immunofluorescent Antibody test (IFAT)
- Enzyme Linked Immunosorbent Assay (ELISA)
- Others
- Parasitological Evaluation
- Punch Biopsy
- Bone Marrow Biopsy
- Others
- DNA- Based Methods
- Nucleic Acid Hybridization
- Polymerase Chain Reaction (PCR)
- Immunological Methods
- Others
Therapy type (Revenue, USD Million; 2016–2026)
- By Drug Therapy
- Pentavalent Antimonials
- Sodium Stibogluconate
- SSG Meglumine antimoniate
- Antifungal
- Antibiotics
- Amphotericin B
- Liposomal amphotericin B
- Miltefosine
- Paromomycin
- Pentamidine
- By Non-Drug Therapy
- Cauterization
- Surgical Excision
- Cryotherapy
End Use Revenue, USD Million; 2016–2026)
- Hospitals
- Clinics
- Diagnostic Laboratory
- Others
Regional analysis further covers a country-wise analysis to offer insights into key trends and demands in each major country that might affect the growth of the market in the region.
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- A.E.
- South Africa
- Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/leishmaniasis-treatment-market
Key Features of the Global Leishmaniasis Treatment Market Report:
- Comprehensive analysis of the key players operating in the market along with their SWOT analysis, their business profiles, business overview, market share, global position, and market value
- Identification and analysis of significant trends and factors driving revenue growth of the market
- Analysis of the competitive landscape along with strategic mergers, expansions, agreements, partnerships, joint ventures, acquisitions, and product launches
- Assessment of each market segment along with their growth trends and market revenue contribution
- Study of the key regions to pinpoint growth potential and study opportunities, threats, limitations, and risks
Request a customization of the report @https://www.reportsanddata.com/request-customization-form/2153
Thank you for reading our report. Customization of this report is available according to the client’s needs. Please get in touch with us to know more about the customization feature and our team will ensure the report is tailored as per your requirements.
Browse more details
